Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03681951
Title First-time-in-human (FTIH) Study of GSK3145095 Alone and in Combination With Other Anticancer Agents in Adults With Advanced Solid Tumors
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors GlaxoSmithKline
Indications

pancreatic ductal adenocarcinoma

Advanced Solid Tumor

triple-receptor negative breast cancer

lung non-small cell carcinoma

melanoma

Therapies

GSK3145095

GSK3145095 + Pembrolizumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.